339 related articles for article (PubMed ID: 12239922)
1. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
[TBL] [Abstract][Full Text] [Related]
2. [Expression of proliferation and apoptosis markers in neoplasms of colon mucosa after cholecystectomy].
Galitskiĭ MV; Khomeriki SG; Nikiforov PA
Eksp Klin Gastroenterol; 2009; (5):28-32. PubMed ID: 20205327
[TBL] [Abstract][Full Text] [Related]
3. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity in colonic adenomas as a predictor of metachronous adenomas as assessed by proliferating cell nuclear antigen immunohistochemistry.
Paspatis GA; Karamanolis DG; Vasilakaki T; Zizi A; Xourgias V; Elemenoglou I; Hadziyannis SJ
Am J Gastroenterol; 1995 Apr; 90(4):597-602. PubMed ID: 7717318
[TBL] [Abstract][Full Text] [Related]
6. Flat elevated lesions of the colon and rectum: a spectrum of neoplastic and nonneoplastic entities.
Gualco G; Reissenweber N; Cliché I; Bacchi CE
Ann Diagn Pathol; 2006 Dec; 10(6):333-8. PubMed ID: 17126250
[TBL] [Abstract][Full Text] [Related]
7. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
8. Polypoid mucosal prolapse complicating low rectal adenomas: beware the inflammatory cloacogenic polyp!
Parfitt JR; Shepherd NA
Histopathology; 2008 Jul; 53(1):91-6. PubMed ID: 18484980
[TBL] [Abstract][Full Text] [Related]
9. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
[TBL] [Abstract][Full Text] [Related]
10. Proliferative patterns of rectal mucosa as predictors of advanced colonic neoplasms in routinely processed rectal biopsies.
Paspatis GA; Zizi A; Chlouverakis GJ; Giannikaki ES; Vasilakaki T; Elemenoglou I; Karamanolis DG
Am J Gastroenterol; 1998 Sep; 93(9):1472-7. PubMed ID: 9732928
[TBL] [Abstract][Full Text] [Related]
11. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
[TBL] [Abstract][Full Text] [Related]
12. Chicken skin mucosa surrounding adult colorectal adenomas is a risk factor for carcinogenesis.
Guan J; Zhao R; Zhang X; Cheng Y; Guo Y; Wang L; Mi L; Liu F; Ma X; Li B
Am J Clin Oncol; 2012 Dec; 35(6):527-32. PubMed ID: 21654311
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
[TBL] [Abstract][Full Text] [Related]
14. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
15. Predictors of the early development of advanced metachronous colon adenomas.
Triantafyllou K; Papatheodoridis GV; Paspatis GA; Vasilakaki TH; Elemenoglou I; Karamanolis DG
Hepatogastroenterology; 1997; 44(14):533-8. PubMed ID: 9164533
[TBL] [Abstract][Full Text] [Related]
16. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
[TBL] [Abstract][Full Text] [Related]
18. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
19. Adenomas of the colon: overexpression of p53 protein and risk factors.
Speroni AH; Vanzulli SI; Meiss RP
Endoscopy; 1998 Sep; 30(7):623-6. PubMed ID: 9826142
[TBL] [Abstract][Full Text] [Related]
20. [Expression of protein p53 in the adenoma-colorectal carcinoma sequence].
Gafà R; Lanza G
Pathologica; 1998 Aug; 90(4):351-6. PubMed ID: 9793394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]